SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
143 hedge funds and large institutions have $436M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 19 closing their positions.
Holders
143
Holders Change
-3
Holders Change %
-2.05%
% of All Funds
3.57%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
60
Reduced
32
Closed
19
Calls
$2M
Puts
$7.67M
Net Calls
-$5.67M
Net Calls Change
-$4.62M
Top Buyers
1 |
1
UBS Group
Zurich,
Switzerland
|
$8.18M |
2 |
2
Balyasny Asset Management
Chicago,
Illinois
|
$4.01M |
3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$6.91M |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$8.82M |
5 |
5
Goldman Sachs
New York
|
$9.62M |